Immunodepletion of gp120 Blocks sCD14 Release From Monocytes
gp120 (μg/mL) . | gp120 MoAb in Immunodepletion . | sCD14 (ng/mL) . |
---|---|---|
0.4 | − | 76 |
0.4 | + | 46 |
0.2 | − | 65 |
0.2 | + | 49 |
gp120 (μg/mL) . | gp120 MoAb in Immunodepletion . | sCD14 (ng/mL) . |
---|---|---|
0.4 | − | 76 |
0.4 | + | 46 |
0.2 | − | 65 |
0.2 | + | 49 |
A separate experiment showed that immunodepletion of gp120 with a gp120-specific MoAb removed the stimulating effect on sCD14-release from monocytes. Adherent monocytes from healthy donors were treated for 72 hours with gp120-immunodepleted solution and compared with equal amounts of liquid from the control gp120 solution (without gp120 MoAb in immunodepletion procedure) in sCD14-releasing ability. Numbers are the mean of duplicates. The concentration of sCD14 in unstimulated culture was 49 ng/mL.